查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1671892

全球 3D 生物列印市场按技术、组件、应用和地区划分

3D Bioprinting Market, By Technology, By Component, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球 3D 生物列印市场规模预估为 29.5 亿美元，预计到 2032 年将达到 85.3 亿美元，2025 年至 2032 年的复合年增长率为 16.4%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 29.5亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025-2032年复合年增长率： 16.40％ 2032 年价值预测 85.3亿美元
图。
3D 生物列印市场-IMG1

报告摘要：

3D生物列印是一种新兴的创新技术，利用3D列印机列印人体组织、器官和生物化学物质，用于医学研究和临床应用。它的工作原理是将活细胞、支架和生长因子分层，以支持活组织形成。这种开创性的方法具有巨大潜力，可以透过解决可移植器官短缺的问题来彻底改变医疗保健。基于电脑辅助设计的生物材料、活细胞和支持因素的精确空间沉积使得能够创建复杂的 3D 组织和器官结构。透过重建组织和器官的原生微环境，3D 生物列印可以加速再生医学领域的发展，并最终满足器官移植的需求。

市场动态：

全球 3D 生物列印市场受到再生医学研究资金筹措和倡议不断增加的推动。器官移植需求的不断增长以及器官捐赠者的短缺正在推动对生物列印技术提供的替代解决方案的投资。有利的监管准则和生物列印组织的商业化正在创造有利可图的机会。然而，列印复杂生物结构的高运作成本和技术挑战是一个限制。此外，缺乏专业技能和临床试验也对广泛采用构成挑战。儘管如此，各公司正在共同努力改进生物材料、细胞相容性和 3D 生物列印机的分辨率。药物动力学测试、个人化药物筛检和罕见疾病建模等新应用领域的出现可能会在预测期内推动市场成长。

本研究的主要特点

  • 本研究报告对全球 3D 生物列印市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
  • 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
  • 全球 3D 生物列印市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球 3D 生物列印市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员将透过用于分析全球 3D 生物列印市场的各种策略矩阵来做出决策。

目录：

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购情景

第 4 章。

  • COVID-19 流行病学
  • 供需方分析
  • 经济影响

5. 全球 3D 生物列印市场（依技术划分）（2020-2032 年）

  • 注射器/挤压生物列印
  • 喷墨生物列印
  • 磁浮列印
  • 雷射辅助生物列印
  • 其他技术

6. 全球 3D 生物列印市场按组件划分（2020-2032 年）

  • 3D生物列印机
  • 生医材料
  • 鹰架

7. 全球 3D 生物列印市场按应用划分（2020-2032 年）

  • 药物测试与开发
  • 再生医学
  • 食品检验
  • 研究
  • 其他用途

8. 全球 3D 生物列印市场（按地区） (2020-2032)

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第九章 竞争格局

  • 公司简介
    • 3D Bioprinting Solutions
    • Advanced Solutions Life Sciences, LLC
    • Allevi Inc.
    • Aspect Biosystems Ltd.
    • Bico group ab
    • Bio3D Technologies Pte. Ltd.
    • Cellink Global
    • Collplant Biotechnologies Ltd.
    • Cyfuse Biomedical KK
    • Electro Optical Systems
    • Envisiontec GmbH
    • Foldink Life Science Technologies
    • Formlabs, Inc.
    • GE Healthcare
    • Inventia Life Science PTY LTD
    • Nano 3D Biosciences, Inc.
    • Optomec Inc.
    • Organovo Holdings, Inc.
    • Pandorum Technologies pvt. ltd.
    • Precise Bio
    • Regemat 3D SL
    • Regenovo Biotechnology Co. Ltd.
    • Renishaw PLC.
    • Revotek Co., Ltd.
    • Rokit Healthcare, Inc.
    • Stratasys Ltd.
    • Vivax Bio, LLC

第 10 章 命运之轮

  • 命运之轮
  • 分析师观点
  • Coherent Opportunity Map（COM）

第 11 章 章节：

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5166

Global 3d Bioprinting Market is estimated to be valued at USD 2.95 Bn in 2025 and is expected to reach USD 8.53 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.95 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 16.40% 2032 Value Projection: USD 8.53 Bn
Figure. 3d Bioprinting Market Share (%), By Region 2025
3D Bioprinting Market - IMG1

Report Description:

3D bioprinting is an emerging and innovative technology that utilizes 3D printers to print human tissues, organs, and biochemicals for medical research and clinical applications. It works by layering live cells, scaffolds, and growth factors capable of supporting the formation of biological tissues. This pioneering approach holds enormous potential in revolutionizing healthcare by addressing the shortage of transplantable organs. It allows the fabrication of complex 3D tissues and organ structures through precise spatial deposition of biomaterials, living cells, and supporting factors based on computer-assisted design. By replicating the native microenvironment of tissues and organs, 3D bioprinting can accelerate the field of regenerative medicine and ultimately address the demand for organ transplants.

Market Dynamics:

The global 3D bioprinting market is driven by rising funding and initiatives for research in regenerative medicines. The growing demand for organ transplants and lack of donors has boosted investments in alternative solutions offered by bioprinting technologies. Favorable regulatory guidelines and commercialization of bioprinted tissues are creating lucrative opportunities. However, high operational costs and technical challenges in printing complex living structures pose constraints. Lack of skilled expertise and clinical trials also challenge widespread adoption. Nonetheless, companies are collaborating to improve biomaterials, cell compatibility, and resolution of 3D bioprinters. The emergence of newer application areas such as pharmacokinetic testing, personalized drug screening, and rare disease modeling can boost the market growth during the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global 3D bioprinting market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global 3D bioprinting market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include 3D Bioprinting Solutions, Advanced Solutions Life Sciences, LLC, Allevi Inc., Aspect Biosystems Ltd., Bico group ab, Bio3D Technologies Pte. Ltd., Cellink Global, Collplant Biotechnologies Ltd., Cyfuse Biomedical K.K., Electro Optical Systems, Envisiontec GmbH, Foldink Life Science Technologies, Formlabs, Inc., GE Healthcare, Inventia Life Science PTY LTD, Nano 3D Biosciences, Inc., Optomec Inc., Organovo Holdings, Inc., Pandorum Technologies pvt. ltd., Precise Bio, Regemat 3D S.L., Regenovo Biotechnology Co. Ltd., Renishaw plc., Revotek co., ltd., Rokit Healthcare, inc., Stratasys Ltd.Vivax Bio, LLC, and Vivax Bio, LLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global 3D bioprinting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global 3D bioprinting market

Market Segmentation

  • By Technology
    • Syringe/extrusion Bioprinting
    • Inkjet Bioprinting
    • Magnetic Levitation Bioprinting
    • Laser-assisted Bioprinting
    • Others
  • By Component
    • 3D Bioprinters
    • Biomaterials
    • Scaffolds
  • By Application
    • Drug Testing and Development
    • Regenerative Medicine
    • Food Testing
    • Research
    • Others
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa
  • Key Players Insights
    • 3D Bioprinting Solutions
    • Advanced Solutions Life Sciences, LLC
    • Allevi Inc.
    • Aspect Biosystems Ltd.
    • Bico group ab
    • Bio3D Technologies Pte. Ltd.
    • Cellink Global
    • Collplant Biotechnologies Ltd.
    • Cyfuse Biomedical K.K.
    • Electro Optical Systems
    • Envisiontec GmbH
    • Foldink Life Science Technologies
    • Formlabs, Inc.
    • GE Healthcare
    • Inventia Life Science PTY LTD
    • Nano 3D Biosciences, Inc.
    • Optomec Inc.
    • Organovo Holdings, Inc.
    • Pandorum Technologies pvt. ltd.
    • Precise Bio
    • Regemat 3D S.L.
    • Regenovo Biotechnology Co. Ltd.
    • Renishaw plc.
    • Revotek co., ltd.
    • Rokit Healthcare, inc.
    • Stratasys Ltd.Vivax Bio, LLC
    • Vivax Bio, LLC

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Component
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global 3D Bioprinting Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global 3D Bioprinting Market, By Technology, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Syringe/ extrusion bioprinting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Inkjet Bioprinting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Magnetic Levitation Bioprinting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Laser Assisted Bioprintings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global 3D Bioprinting Market, By Component, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • 3D Bioprinters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Scaffolds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global 3D Bioprinting Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Drug Testing and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Food Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global 3D Bioprinting Market, By Region, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Country Trends
  • North America
    • Regional Trends
    • Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
    • Market Size and Forecast, By Components, 2020-2032 (USD Billion)
    • Market Size and Forecast, By Application, 2020-2032 (USD Billion)
    • Market Share Analysis, By Country, 2025 and 2032 (%)
      • U.S.
      • Canada
  • Europe
    • Regional Trends
    • Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
    • Market Size and Forecast, By Components, 2020-2032 (USD Billion)
    • Market Size and Forecast, By Application, 2020-2032 (USD Billion)
    • Market Share Analysis, By Country, 2025 and 2032 (%)
      • U.K.
      • Germany
      • France
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Regional Trends
    • Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
    • Market Size and Forecast, By Components, 2020-2032 (USD Billion)
    • Market Size and Forecast, By Application, 2020-2032 (USD Billion)
    • Market Share Analysis, By Country, 2025 and 2032 (%)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Regional Trends
    • Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
    • Market Size and Forecast, By Components, 2020-2032 (USD Billion)
    • Market Size and Forecast, By Application, 2020-2032 (USD Billion)
    • Market Share Analysis, By Country, 2025 and 2032 (%)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
    • Market Size and Forecast, By Components, 2020-2032 (USD Billion)
    • Market Size and Forecast, By Application, 2020-2032 (USD Billion)
    • Market Share Analysis, By Country/region, 2025 and 2032 (%)
      • South Africa
      • GCC Countries
      • Rest of the Middle East & Africa

9. Competitive Landscape

  • Company Profiles
    • 3D Bioprinting Solutions*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments/Updates
    • Advanced Solutions Life Sciences, LLC
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments/Updates
    • Allevi Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments/Updates
    • Aspect Biosystems Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments/Updates
    • Bico group ab
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments/Updates
    • Bio3D Technologies Pte. Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments/Updates
    • Cellink Global
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments/Updates
    • Collplant Biotechnologies Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments/Updates
    • Cyfuse Biomedical K.K.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments/Updates
    • Electro Optical Systems
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments/Updates
    • Envisiontec GmbH
    • Foldink Life Science Technologies
    • Formlabs, Inc.
    • GE Healthcare
    • Inventia Life Science PTY LTD
    • Nano 3D Biosciences, Inc.
    • Optomec Inc.
    • Organovo Holdings, Inc.
    • Pandorum Technologies pvt. ltd.
    • Precise Bio
    • Regemat 3D S.L.
    • Regenovo Biotechnology Co. Ltd.
    • Renishaw PLC.
    • Revotek Co., Ltd.
    • Rokit Healthcare, Inc.
    • Stratasys Ltd.
    • Vivax Bio, LLC

10. Wheel of Fortune

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Section:

  • Research Methodology
  • About Us